Clinical Trial

Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study

Study acronym: PRECLUDE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-arm, open label, clinical outcome study to research the durability (success) of receiving a pulsed field ablation (PFA) per standard of care for treatment of atrial fibrillation during a subsequent procedure for the insertion of a left atrial appendage occlusion (LAAO) device. The reassessment of the initial ablation will be performed with or without additional ablation if needed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-27.
Trial Details
NCT Number NCT07620262
Lead Sponsor Northwell Health
Collaborators: Boston Scientific Corporation
Conditions Atrial Fibrillation (AF)
Enrollment 50 participants
Start Date 2026-05-01
Primary Completion 2028-05 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-17